ClinicalTrials.gg

Program

E6742

A development code.

Its studies are mostly in Lupus Erythematosus, Systemic, led by Eisai.

Furthest: phase 2, since Mar 4, 20224 company-led studies, 1 open or runningNext primary completion: Aug 5, 2028 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Eisai41 open or runningphase 2since Mar 4, 2022Mar 14, 2017Aug 5, 2028phase 2 · NCT07515014

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 14, 2017First study: phase 1 study in Healthy ParticipantsFirst studyNCT03082235 · 72 enrolled · United States
  2. Dec 21, 2020Phase 1 study in Healthy VolunteersNCT04683185 · 24 enrolled · Japan
  3. Mar 4, 2022Phase 2 study in Lupus Erythematosus, SystemicNCT05278663 · 26 enrolled · Japan
  4. Mar 11, 2026Phase 2 study in Lupus Erythematosus, SystemicNCT07515014 · 256 planned · China, Japan, South Korea and more

Ahead

  1. Aug 5, 2028Primary completion: phase 2 study in Lupus Erythematosus, SystemicNCT07515014

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07515014Lupus Erythematosus, Systemic · China, Japan, South Korea and more2RecruitingAug 5, 2028256
NCT05278663Lupus Erythematosus, Systemic · Japan2CompletedSep 4, 202326
NCT04683185Healthy Volunteers · Japan1CompletedJun 21, 202124
NCT03082235Healthy Participants · United States1CompletedOct 11, 201772

How it is read

Names in the registry

  • “E6742”, 4 entries

Codes read as this program: E6742.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.